Drawing for ARC

USPTO serial 79315422

ARC

Reviewed by CopyMark Law Group

Reg. 6874545Status 700Registered
Filing date
Status date
Registration date
Oct 18, 2022
Examiner
JOINER, KATINA JACKSON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ARC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JACQUELINE ZION

JACQUELINE ZION PEARL COHEN ZEDEK LATZER BARATZ LLP7 TIMES SQUARE 19TH FLNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Consultancy relating to the commercialization of medical products and technologies; business management of all types (commercial, operation, development and marketing) of development centers and business incubators in the fields of medical products and technologies; commercialization of medical products and technologies; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposes, veterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticals, anti-cancer preparations, biological preparations, or vaccine preparationsACTIVE—
042Consultancy relating to the development of medical products and technologies; design and development of medical products and technologies; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposes, veterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticals, anticancer preparations, biological preparations, or vaccine preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 5, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2023IRGPIRREGULARITY ON GRANT OF PROTECTION RECEIVED FROM IB—
Feb 2, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 2, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 18, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 18, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 18, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 14, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS—
Sep 14, 2022OP.TOPPOSITION TERMINATED NO. 999999—
Sep 14, 2022OP.DOPPOSITION DISMISSED NO. 999999—
May 10, 2022CHPBPOST PUBLICATION AMENDMENT - ENTERED—
May 10, 2022APETASSIGNED TO PETITION STAFF—
May 9, 2022RFNPREFUSAL PROCESSED BY IB—
Apr 26, 2022OP.IOPPOSITION INSTITUTED NO. 999999—
Apr 19, 2022OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Apr 19, 2022OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Apr 18, 2022EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 16, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2021NPUBNOTICE OF PUBLICATION—
Sep 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2021DOCKASSIGNED TO EXAMINER—
Jul 20, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 16, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 15, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance